HOUSTON--(BUSINESS WIRE)--DecisionDx-GBM - brain cancer test is a molecular diagnostic test developed at and licensed from The University of Texas M. D. Anderson Cancer Center. The test is used to prospectively predict patient outcome to treatment for glioblastoma multiforme (GBM), the most common form of primary brain cancer.